Fonville J M, Wilks S H, James S L, Fox A, Ventresca M, Aban M, Xue L, Jones T C, Le N M H, Pham Q T, Tran N D, Wong Y, Mosterin A, Katzelnick L C, Labonte D, Le T T, van der Net G, Skepner E, Russell C A, Kaplan T D, Rimmelzwaan G F, Masurel N, de Jong J C, Palache A, Beyer W E P, Le Q M, Nguyen T H, Wertheim H F L, Hurt A C, Osterhaus A D M E, Barr I G, Fouchier R A M, Horby P W, Smith D J
Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.
WHO Collaborating Center for Modeling, Evolution, and Control of Emerging Infectious Diseases, Cambridge CB2 3EJ, UK.
Science. 2014 Nov 21;346(6212):996-1000. doi: 10.1126/science.1256427.
We introduce the antibody landscape, a method for the quantitative analysis of antibody-mediated immunity to antigenically variable pathogens, achieved by accounting for antigenic variation among pathogen strains. We generated antibody landscapes to study immune profiles covering 43 years of influenza A/H3N2 virus evolution for 69 individuals monitored for infection over 6 years and for 225 individuals pre- and postvaccination. Upon infection and vaccination, titers increased broadly, including previously encountered viruses far beyond the extent of cross-reactivity observed after a primary infection. We explored implications for vaccination and found that the use of an antigenically advanced virus had the dual benefit of inducing antibodies against both advanced and previous antigenic clusters. These results indicate that preemptive vaccine updates may improve influenza vaccine efficacy in previously exposed individuals.
我们介绍了抗体图谱,这是一种通过考虑病原体菌株间的抗原变异来定量分析针对抗原可变病原体的抗体介导免疫的方法。我们生成了抗体图谱,以研究69名在6年中接受感染监测的个体以及225名接种疫苗前后的个体的免疫谱,这些免疫谱涵盖了甲型H3N2流感病毒43年的进化历程。感染和接种疫苗后,抗体滴度普遍升高,包括先前遇到的病毒,其超出了初次感染后观察到的交叉反应范围。我们探讨了其对疫苗接种的影响,发现使用抗原性更先进的病毒具有诱导针对先进和先前抗原簇的抗体的双重益处。这些结果表明,抢先更新疫苗可能会提高先前接触过流感病毒个体的流感疫苗效力。